| RE49825 |
Piperidinyl nociceptin receptor compounds |
Nurulain Zaveri |
2024-02-06 |
|
| 10112924 |
Piperdinyl nociceptin receptor compounds |
Nurulain Zaveri |
2018-10-30 |
|
| 8906911 |
Chemokine receptor antagonists |
Xueqing Wang, Tao Guo, Robert Guo Ping Wei, Lijuan Wang |
2014-12-09 |
$81,481,000 |
| 8481574 |
Compounds as cannabinoid receptor ligands |
Michael J. Dart, William A. Carroll, Meena Patel, Tedozyi Kolasa, Xueqing Wang |
2013-07-09 |
$14,335,000 |
| 7750039 |
Indoles are cannabinoid receptor ligands |
Jennifer M. Frost, Karin R. Tietje, Michael J. Dart |
2010-07-06 |
$51,963,000 |
| 7560481 |
Indoles are cannabinoid receptor ligands |
Jennifer M. Frost, Karin R. Tietje, Michael J. Dart |
2009-07-14 |
$115,278,000 |
| 7265115 |
Diazabicyclic CNS active agents |
William H. Bunnelle, Daniela Barlocco Cristina, Jerome F. Daanen, Michael J. Dart, Keith B. Ryther +3 more |
2007-09-04 |
$324,611,000 |
| 6503935 |
Imidazoles and related compounds as &agr;1A agonists |
Robert J. Altenbach, James F. Kerwin, Jr., Mark W. Holladay, Albert Khilevich, Teodozyj Kolasa +2 more |
2003-01-07 |
$92,205,000 |
| 6166019 |
Piperazinyl pyrimidine dione compounds selective for adrenoceptors |
William A. Caroll |
2000-12-26 |
$113,176,000 |
| 6153614 |
Piperazinyl pyrimidine dione compounds selective for adrenoceptors |
William A. Carroll |
2000-11-28 |
$479,933,000 |
| 6133275 |
3-phenylpyrrolidine alpha-1 adrenergic compounds |
Paul P. Ehrlich, Jeffrey W. Ralston, Jerome F. Daanen |
2000-10-17 |
$192,650,000 |
| 6046207 |
Benzopyranopyrrole and benzopyranopyridine .alpha.-1 adrenergic compounds |
Robert J. Altenbach, Fatima Z. Basha, William A. Carroll, Irene Drizin, James F. Kerwin, Jr. +3 more |
2000-04-04 |
|
| 5891882 |
Benzopyranopyrrole and benzopyranopyridine .alpha.-1 adenergic compounds |
Robert J. Altenbach, Fatima Z. Basha, William A. Carroll, Irene Drizin, James F. Kerwin, Jr. +1 more |
1999-04-06 |
$39,953,000 |
| 5792767 |
Bicyclic substituted hexahydrobenz e! isoindole alpha-1 adrenergic antagonists |
Robert J. Altenbach, Fatima Z. Basha, William A. Carroll, Irene Drizin, James F. Kerwin, Jr. +6 more |
1998-08-11 |
$102,410,000 |
| 5597823 |
Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists |
Robert J. Altenbach, Fatima Z. Basha, William A. Carroll, Irene Drizin, Steven W. Elmore +6 more |
1997-01-28 |
$22,309,000 |
| 5521181 |
Bicyclic substituted hexahydrobenz[e]isoindole .alpha.-1 adrenergic antagonists |
Robert J. Altenbach, William A. Carroll, Irene Drizin, Suzanne A. Lebold, Edmund L. Lee +4 more |
1996-05-28 |
$64,717,000 |
| 5288749 |
Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors |
John F. DeBernardis, Rajnandan N. Prasad, Kevin B. Sippy, Karin R. Tietje |
1994-02-22 |
$25,677,000 |
| 5244888 |
5-HT selective agents |
John F. DeBernardis, Kevin B. Sippy |
1993-09-14 |
$41,479,000 |
| 5049564 |
5-HT selective agents |
John F. DeBernardis, Kevin B. Sippy |
1991-09-17 |
$105,559,000 |
| 4963568 |
Dopamine agonists |
Robert W. Schoenleber, John W. Kebabian, Yvonne C. Martin, Michael P. DeNinno, Richard J. Perner +6 more |
1990-10-16 |
$28,538,000 |
